Philip Ashman
Net Worth
Last updated:
What is Philip Ashman net worth?
The estimated net worth of Dr. Philip Ashman is at least $2,981,893 as of 8 Apr 2021. He has earned $61,913 from insider trading and has received compensation worth at least $2,919,980 in Alimera Sciences, Inc..
What is the salary of Philip Ashman?
Dr. Philip Ashman salary is $417,140 per year as Chief Operating Officer & Senior Vice President of Commercial Operations - Europe in Alimera Sciences, Inc..
How old is Philip Ashman?
Dr. Philip Ashman is 60 years old, born in 1965.
What stocks does Philip Ashman currently own?
As insider, Dr. Philip Ashman owns shares in one company:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| Alimera Sciences, Inc. (ALIM) | Chief Operating Officer & Senior Vice President of Commercial Operations - Europe | 19,379 | $0 | $0 |
What does Alimera Sciences, Inc. do?
Alimera Sciences, Inc., a pharmaceutical company, engages in the development and commercialization of ophthalmic pharmaceuticals in the United States and internationally. It offers ILUVIEN, an intravitreal implant for the treatment of diabetic macular edema (DME), which is a disease of the retina that affects individuals with diabetes and lead to severe vision loss and blindness; and to prevent relapse in recurrent non-infectious uveitis affecting the posterior segment of the eye. The company sells its products to physician offices, pharmacies, and hospitals through direct sales and distributors. It has a collaboration agreement with EyePoint Pharmaceuticals US, Inc. for the development and sale of insert technology to deliver other corticosteroids to the back of the eye for the treatment and prevention of eye diseases in humans or to treat diabetic macular edema. The company was incorporated in 2003 and is headquartered in Alpharetta, Georgia.
Philip Ashman insider trading
Alimera Sciences, Inc.
Dr. Philip Ashman has made 5 insider trades between 2018-2021, according to the Form 4 filled with the SEC. Most recently he sold 45 units of ALIM stock worth $433 on 8 Apr 2021.
The largest trade he's ever made was exercising 12,750 units of ALIM stock on 16 Jan 2018. As of 8 Apr 2021 he still owns at least 19,379 units of ALIM stock.
Alimera Sciences key executives
Alimera Sciences, Inc. executives and other stock owners filed with the SEC:
- Dr. Philip Ashman (60) Chief Operating Officer & Senior Vice President of Commercial Operations - Europe
- Mr. Charles Daniel Myers (71) Non-Executive Chairman & Consultant
- Mr. David R. Holland (61) Co-Founder, Chief Marketing Officer and Senior Vice President of Corporation Communications & Managed Markets
- Mr. Richard S. Eiswirth Jr. (57) Pres, Chief Executive Officer & Director